Surrey researchers Sign in
Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial
Journal article

Morning vs evening dosing of the cathepsin K inhibitor ONO-5334: effects on bone resorption in postmenopausal women in a randomized, phase 1 trial

R Eastell, D-J Dijk, M Small, A Greenwood, J Sharpe, H Yamada, M Yuba, M Tanimoto and S Deacon
OSTEOPOROSIS INTERNATIONAL, Vol.27(1), pp.309-318
01/01/2016

Abstract

Science & Technology Life Sciences & Biomedicine Endocrinology & Metabolism Anti-resorptive Bone resorption Menopause Osteoporosis BIOCHEMICAL MARKERS CIRCADIAN VARIATION MINERAL DENSITY CORTICAL BONE OSTEOPOROSIS TURNOVER THERAPY ODANACATIB PHARMACOKINETICS ALENDRONATE
url
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369525500036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11d2a86992e85fb529977dad66a846d5View
Author

Metrics

Details

Usage Policy